When and how to use the CDK4/6 inhibitor in metastatic breast cancer

Date 20 December 2015
Event ESMO Asia 2015 Congress
Session When and how to use the CDK4/6 inhibitor in metastatic breast cancer
Topics Anti-Cancer Agents & Biologic Therapy
Breast Cancer, Metastatic
Personalised Medicine
Presenter Masakazu Toi
Authors M. Toi
  • Department Of Breast Surgery, Kyoto University Hospital, 606-8507 - Kyoto/JP